caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1588684781

Thomas Fitzpatrick

Family PracticeBurns, ORI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Thomas Fitzpatrick's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 18 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Seattle, WA
2631,205
HARNEY DISTRICT HOSPITAL2403,128
Jennifer Keady
Optometry · Burns, OR
4192
Stephen Pool
Pathology · Redmond, OR
3585
Garrett Schroeder
Diagnostic Radiology · Bend, OR
2463
John Stassen
Diagnostic Radiology · Bend, OR
2381
Cloe Shelton
Diagnostic Radiology · Lebanon, NH
2379
ZULAUF, DAVID2283
Sarah Laiosa
Family Practice · Burns, OR
22178
HARNEY DISTRICT HOSPITAL1996
Unilab Corporation
Clinical Laboratory · West Hills, CA
1889
Traci Clautice-Engle
Diagnostic Radiology · Bend, OR
1751
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
2,289
Beneficiaries
—
Total drug cost
$94K
Distinct drugs
54
Brand share
13.7%
Top prescribed drugs
Atorvastatin Calcium148 claims
Amlodipine Besylate146 claims
Levothyroxine Sodium141 claims
Gabapentin106 claims
Losartan Potassium104 claims
QUALITY · MIPS · 2024
Final MIPS score
88.7
Quality
71.2
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.58%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.